[HTML][HTML] Use of the informational spectrum methodology for rapid biological analysis of the novel coronavirus 2019-nCoV: prediction of potential receptor, natural …
V Veljkovic, J Vergara-Alert, J Segalés… - F1000Research, 2020 - ncbi.nlm.nih.gov
A novel coronavirus recently identified in Wuhan, China (SARS-CoV-2) has expanded the
number of highly pathogenic coronaviruses affecting humans. The SARS-CoV-2 represents …
number of highly pathogenic coronaviruses affecting humans. The SARS-CoV-2 represents …
Identifying potential gene defect patterns related to COVID-19 based on pharmacological and bioinformatics analysis for lung adenocarcinoma
H Lou, X Li, S Gao, Y Zhang, H Chen… - International journal of …, 2022 - Taylor & Francis
Abstract Background Coronavirus disease 2019 (COVID-19) greatly affects cancer patients,
especially those with lung cancer. This study aimed to identify potential drug targets for lung …
especially those with lung cancer. This study aimed to identify potential drug targets for lung …
[PDF][PDF] Current Research in Microbial Sciences
TB Mahmooda, AS Chowdhurya… - Current Research in …, 2021 - academia.edu
abstract Coronavirus disease-2019 (COVID-19) is a recent world pandemic disease that is
caused by a newly discovered strain of the Severe Acute Respiratory Syndrome …
caused by a newly discovered strain of the Severe Acute Respiratory Syndrome …
IDDF2021-ABS-0195 SARS-COV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients
W Liu, H Chen, Y Wang, D Liu, L Zhao, J Yu - 2021 - gut.bmj.com
Background The outbreak of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-
2 infection has become a global health emergency. We aim to decipher SARS-CoV-2 …
2 infection has become a global health emergency. We aim to decipher SARS-CoV-2 …
Predictive Analysis of Susceptibility of Different Species to SARS-CoV-2 based on ACE2 Receptors
Coronavirus Disease 2019 (COVID-19) is a pulmonary inflammatory disease caused by
infection with the highly pathogenic new coronavirus (SARS-CoV-2)[1]. To date, COVID-19 …
infection with the highly pathogenic new coronavirus (SARS-CoV-2)[1]. To date, COVID-19 …
Integration of transcriptomic profile of SARS-CoV-2 infected normal human bronchial epi-thelial cells with metabolic and protein-protein interaction networks
HU Karakurt, P Pir - Turkish journal of biology, 2020 - journals.tubitak.gov.tr
A novel coronavirus (SARS-CoV-2, formerly known as nCoV-2019) that causes an acute
respiratory disease has emerged in Wuhan, China and spread globally in early 2020. On …
respiratory disease has emerged in Wuhan, China and spread globally in early 2020. On …
Airways expression of SARS-CoV-2 receptor, ACE2, and TMPRSS2 is lower in children than adults and increases with smoking and COPD
NS Sharif-Askari, FS Sharif-Askari, M Alabed… - … Therapy Methods & …, 2020 - cell.com
It has been reported that angiotensin-converting enzyme 2 (ACE2) and transmembrane
serine protease 2 (TMPRSS2) are the main cell entry proteins for severe acute respiratory …
serine protease 2 (TMPRSS2) are the main cell entry proteins for severe acute respiratory …
Considerations in treating patients with advance lung cancer during the epidemic outbreak of novel coronavirus (SARS-CoV-2)
Y Cai, Y Xu, D Xu, Y Wang, X Wang, C Sun, Y Guo… - Medical Oncology, 2020 - Springer
The outbreak of pneumonia caused by novel coronavirus (SARS-CoV-2) in Wuhan, China,
at the end of 2019 quickly escalated into a global health emergency. Since its outbreak until …
at the end of 2019 quickly escalated into a global health emergency. Since its outbreak until …
[HTML][HTML] Discovery of the Retinol STRA6 Receptor as a Novel Binding Receptor for SARS-CoV-2 in COVID-19: In Silico Research.
Background: The COVID-19 pandemic caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has infected over 100 million people causing over 2.4 million …
coronavirus 2 (SARS-CoV-2) has infected over 100 million people causing over 2.4 million …